11.95
price down icon4.78%   -0.60
pre-market  Pre-market:  11.19   -0.76   -6.36%
loading

Pliant Therapeutics Inc Stock (PLRX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - 0.248 1.332
Operating Expenses
11.38%
52.39
47.04 47.69 47.58 43.43
Interest Income/Expense
38.63%
0.445
0.321 0.317 0.319 0.311
Operating Income/Loss
11.38%
-52.39
-47.04 -47.69 -47.33 -42.09
Income/Loss From Continuing Operations Before Tax
-46.95
- -41.49 -41.19 -37.55
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
14.22%
-46.95
-41.11 -41.49 -41.19 -37.55
Net Income/Loss
14.22%
-46.95
-41.11 -41.49 -41.19 -37.55
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,965%
60.18
0.3995 59.69 59.17 56.06
Diluted Average Shares
14,965%
60.18
0.3995 59.69 59.17 56.06
Basic Earnings Per Share
13.04%
-0.78
-0.69 -0.70 -0.70 -0.67
Diluted Earnings Per Share
13.04%
-0.78
-0.69 -0.70 -0.70 -0.67
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):